Published On: Mon, Jun 19th, 2017

Reviewing Individual Broker Targets Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)


Recently stock market analysts have updated their consensus ratings on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART).

Most recent broker ratings

06/07/2017 – Integra LifeSciences Holdings Corporation had its “buy” rating reiterated by analysts at UBS. They now have a USD 60 price target on the stock.

05/31/2017 – Integra LifeSciences Holdings Corporation had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 58 price target on the stock.

05/02/2017 – Integra LifeSciences Holdings Corporation had its “sector perform” rating reiterated by analysts at RBC Capital. They now have a USD 48 price target on the stock.

03/22/2017 – Integra LifeSciences Holdings Corporation had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 47 price target on the stock.

01/12/2017 – Integra LifeSciences Holdings Corporation had its “equal-weight” rating reiterated by analysts at Barclays. They now have a USD 42 price target on the stock.

01/06/2017 – Integra LifeSciences Holdings Corporation was upgraded to “market outperform” by analysts at JMP Securities. They now have a USD 50 price target on the stock.

10/28/2016 – Integra LifeSciences Holdings Corporation was upgraded to “buy” by analysts at Lake Street. They now have a USD 92 price target on the stock.

10/04/2016 – Integra LifeSciences Holdings Corporation had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 93 price target on the stock.

09/23/2016 – Integra LifeSciences Holdings Corporation had its “buy” rating reiterated by analysts at Argus. They now have a USD 105 price target on the stock.

07/13/2016 – Integra LifeSciences Holdings Corporation had its “overweight” rating reiterated by analysts at JP Morgan.

11/12/2015 – Citigroup began new coverage on Integra LifeSciences Holdings Corporation giving the company a “buy” rating. They now have a USD 75 price target on the stock.

09/21/2015 – Integra LifeSciences Holdings Corporation was upgraded to “buy” by analysts at Bank of America Merrill Lynch. They now have a USD 79 price target on the stock.

07/29/2015 – Integra LifeSciences Holdings Corporation was upgraded to “outperform” by analysts at Raymond James.

05/05/2015 – Integra LifeSciences Holdings Corporation was upgraded to “buy” by analysts at Zacks. They now have a USD 73 price target on the stock.

05/04/2015 – Integra LifeSciences Holdings Corporation was upgraded to “outperform” by analysts at Wells Fargo.

Integra LifeSciences Holdings Corporation has a 50 day moving average of 48.87 and a 200 day moving average of 51.04. The stock’s market capitalization is 3.99B, it has a 52-week low of 40.51 and a 52-week high of 88.86.

The share price of the company (NASDAQ:IART) was up +0.13% during the last trading session, with a high of 53.07 and the volume of Integra LifeSciences Holdings Corporation shares traded was 924301.